» Articles » PMID: 14740811

A Case Series of Temporomandibular Disorders Treated with Acupuncture, Occlusal Splint and Point Injection Therapy

Overview
Journal Acupunct Med
Publisher Sage Publications
Date 2004 Jan 27
PMID 14740811
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A treatment regime combining acupuncture, occlusal splint and point injection therapy for temporomandibular disorders (TMD) is presented. There were 89 consecutive patients treated by the regime in this case series but four patients dropped out after two to three visits. Data and treatment results of the remaining 85 patients who had treatment completed were analysed. It was found that 73 (85%) of patients with TMD had symptoms relieved within six visits under this regime. Complications were rare and minor. Acupuncture treatment, in combination with splint therapy and point injection therapy, appears to be effective for managing TMD. However, further research, using randomised controlled trials should be conducted to ascertain its effectiveness over other treatment modalities.

Citing Articles

Evaluation of the effects of occlusal splint and masseter muscle injection in patients with myofascial pain: a randomised controlled trial.

Saglam R, Delilbasi C, Sayin Ozel G, Subasi I J Oral Facial Pain Headache. 2025; 38(3):64-76.

PMID: 39800573 PMC: 11810675. DOI: 10.22514/jofph.2024.028.


The relationship between spinal pain and temporomandibular joint disorders in Korea: a nationwide propensity score-matched study.

Kim D, Ko S, Lee E, Jung B BMC Musculoskelet Disord. 2019; 20(1):631.

PMID: 31884949 PMC: 6935481. DOI: 10.1186/s12891-019-3003-4.


Acupoint injection of onabotulinumtoxin A for migraines.

Hou M, Xie J, Kong X, Zhang Y, Shao Y, Wang C Toxins (Basel). 2015; 7(11):4442-54.

PMID: 26529014 PMC: 4663513. DOI: 10.3390/toxins7114442.


Ear Acupuncture Therapy for Masticatory Myofascial and Temporomandibular Pain: A Controlled Clinical Trial.

Ferreira L, Grossmann E, Januzzi E, Rosa Ferraz Goncalves R, Mares F, de Paula M Evid Based Complement Alternat Med. 2015; 2015:342507.

PMID: 26351510 PMC: 4553336. DOI: 10.1155/2015/342507.


Botulinum toxin type a therapy in migraine: preclinical and clinical trials.

Shao Y, Zhang Y, Zhao P, Yan W, Kong X, Fan L Iran Red Crescent Med J. 2014; 15(10):e7704.

PMID: 24693369 PMC: 3950781. DOI: 10.5812/ircmj.7704.